With the use of new magnetic resonance imaging (MRI)-conditional pacing technology, pacemaker patients will have access to full body scanners, without positioning restriction in the MRI scanner.
A European health agency has recommended marketing authorization for Amyvid (florbetapir 18F) as a diagnostic imaging agent in patients who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive decline.
Newly developed technology provides three-dimensional (3D) X-ray imaging of the breast with a radiation dose that is lower than the current 2D X-ray imaging used in clinics.
Heart catheter procedures guided by magnetic resonance imaging (MRI) are as safe as X-ray-guided procedures and do not take any longer, according to a pilot study.
The United States Preventive Services Task Force recommends against the use of estrogen and progestin for the prevention of chronic medical conditions in postmenopausal women
A new Digital Imaging and Communications in Medicine (DICOM) application features proprietary data tagging technology, which allows healthcare enterprises to have complete control over security of their patient data.